Dr Reddy's launches bladder management drug
Dr Reddy’s Laboratories, an emerging global pharmaceutical company, has launched Bispec (solifencin succinate) in India.
Used in the management of over active bladder (OAB), Bispec is the best-in-class for OAB and, has lesser incidence of dry mouth and constipation.
People suffering from OAB have a warning time of about 12 seconds.
Solifencin Succinate helps increase the warning time to about 32 seconds.
Bispec is available in tablet form, and in dosages of 5 mg and 10 mg.